Hashiguchi, Yojiro http://orcid.org/0000-0002-6178-2574
Muro, Kei
Saito, Yutaka
Ito, Yoshinori
Ajioka, Yoichi
Hamaguchi, Tetsuya
Hasegawa, Kiyoshi
Hotta, Kinichi
Ishida, Hideyuki
Ishiguro, Megumi
Ishihara, Soichiro
Kanemitsu, Yukihide
Kinugasa, Yusuke
Murofushi, Keiko
Nakajima, Takako Eguchi
Oka, Shiro
Tanaka, Toshiaki
Taniguchi, Hiroya
Tsuji, Akihito
Uehara, Keisuke
Ueno, Hideki
Yamanaka, Takeharu
Yamazaki, Kentaro
Yoshida, Masahiro
Yoshino, Takayuki
Itabashi, Michio
Sakamaki, Kentaro
Sano, Keiji
Shimada, Yasuhiro
Tanaka, Shinji
Uetake, Hiroyuki
Yamaguchi, Shigeki
Yamaguchi, Naohiko
Kobayashi, Hirotoshi
Matsuda, Keiji
Kotake, Kenjiro
Sugihara, Kenichi
,
Article History
Received: 23 May 2019
Accepted: 29 May 2019
First Online: 15 June 2019
Compliance with ethical standards
:
: (1) The following corporations were disclosed by self-declaration of the Guideline Committee members and Guideline Evaluation Committee members. (2) A2 Healthcare Corp., Akita Sumitomo Co., Ltd., Array Biopharma Inc., Astellas Pharma Inc., Bayer Yakuhin, Ltd., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Covidien Japan, Inc., DAIICHI SANKYO COMPANY, Ltd., EA Pharma Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Gilead Sciences, Inc., Intuitive Surgical, Inc., Japan Clinical Research Operations, Johnson & Johnson K.K., Kaigen Pharma Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Mediscience Planning Inc., Merck Serono Co., Ltd., Merck Biopharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, MRP Co., Ltd., MSD K.K., NanoCarrier Co., Ltd., Nippon Boehringer lngelheim Co., Ltd., Olympus Corporation, Ono pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K., Shimadzu Corporation, Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Sysmex Corporation, Taiho pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., TERUMO CORPORATION, Yakult Honsha Co., Ltd. ((2) Measures for the conflicts of interest:The Guideline Committee and the Guideline Evaluation Committee have been organized in members with a diverse range of disciplines, including surgery, internal medicine, radiology, pathology, etc., in order to minimize biased opinion. Each recommendation was made determined not on an individual opinion basis but based on voting by the whole committee members, with consensus prioritized. When voting for CQ, conflicts in relation to economic and academic interests were confirmed for each CQ, and members with conflicts of interest in the CQ abstained from voting.